Naltrexone in the treatment of alcoholism. Clinical evolution, safety and efficacy in a sample of 198 patients;Evolución clínica del alcoholismo tratado con naltrexona. Efectividad y seguridad en una muestra de 198 pacientes

Medicina Clinica

Volumn 116, Issue 14, 2001, Pages 526-532

  Gual Solé, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Alcohol; Craving; Naltrexone; Predictive prognostic factors; Safety

Indexed keywords

NALTREXONE;

ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; ASTHENIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA AND VOMITING; SOMNOLENCE; TREATMENT OUTCOME;

EID: 0343337174     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71894-5     Document Type: Article

References (23)

1. San L. Tratamiento de la dependencia del alcohol: abstinencia total o parcial. Psiquiatr Biol 1998; 5: 129-133.
2. Pérez-Castello I, Soler Company E. Faus Soler MT, Faus Morant R, Olcira Rodriguez H, Cuenca Soria A Naltrexona en el tratamiento do la alcoholdependencia. Aten Farm 1999; 1: 263-274.
3. Gianoulakis C, Barcomb A. Effect of acute ethanol in vivo and in vitro on the Beta-Endorphin system in the rat. Life Sci 1987; 40: 19-28.
4. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavumdayil J, Tawar V, Dumas M. Different pituitary Beta-Endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for development of alcoholism. Life Sci 1989; 45: 1097-1109.
5. Volpicelli JR, Merman A. Havasrica M, O'Brien CH. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876-880.
6. O'Malley S Jaffe AJ, Chang G Schottenfeld R, Meyer RE. Founsanville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Anch Gen Psychiatry 1992; 49: 881-887.
7. Croop RS. The safety profile of naltrexone in the treatment of alcoholism. Arch Gen Psychiatry 1997 54: 1130-1135.
8. Gual A, Martos AR, Lligona A. Llopis JJ. Does the concept of a standart drink apply to viticultural societies? Alcohol 1999; 34: 153-160.
9. Batel P, Pessione F, Michaud P, Lauvin L, Reliquet LM, Gache P et al. Consommation d'alcool a 3 mois de 215 patients alcooldependants traites par la naltrexone. Une etude euverte multicentrique. Alcologie 1999; 21: 429-434.
10. Croop RS, Faulkner EB, Labriola DF The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage stucy. The Naltrexone Usage Study Group. Arch Gen Psychiatry 1997; 54: 1130-1135.
11. Berg BJ, Petinati HM, Volpicelli JR. A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Safety 1996; 15: 274-282.
12. Volpicelli JR, Volpicelli LA, O'Brien CP. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Alcohol and Alcoholism 1995; 30: 789-798.
13. Brahen LS, Capon TJ, Capone DM. Naltrexone: lack of effect on hepatic enzymes. J Clin Pharmacol 1988; 28: 64-70.
14. Volpicelli JR, O'Brien Ch. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 1995; 56: 39-44.
15. Volpicelli JR, Watson NT, King A, Sherman CE, O'Brien CH. Effect of naltrexone on alcohol «high» in alcoholics. Am J Psychiatry 1995; 152: 613-615.
16. O'Malley S, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence Arch Gen Psychiatry 1996; 53: 217-224.
17. O'Malley S, Croop RS, Wroblewski JM, Labriola DF, Volpicelli JR. Naltrexone in the treatment of alcohol dependence: a combined analysis of two trials. Psychiatric Annals 1995; 25: 681-688.
18. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CH. Naltrexone and alcohol dependence. Arch Gen Psychiatry 1997; 54: 737-742.
19. Pini LA, Ferretti C, Trenti T, Ferrari A, Sternieri E. Effects of long-term treatment with naltrexone on hepatic enzyme activity. Drug Metab Drug Interact 1991; 9: 161-174.
20. O'Malley S, Jaffe AJ, Rode S, Rousanville BJ. Experience of a «slip» among alcoholics treated with naltrexone or placebo. Am J Psychiatry 1996; 153: 281-283
21. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999; 156: 1758-1764
22. Guardia J, Caso C, Gual A, Sanahuja J, Ramírez ML, Mengual I et al. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder. Results from a multicenter clinical trial. En prensa.
23. Kadden RM Project MATCH: treatment main effects and matching results. Alcohol Clin Exp Res 1996; 20: A196-A197.